Freedom Meditech Gets Additional Financing

San Diego-based Freedom Meditech, a developer of medical devices for measuring blood sugar in the diabetic, said today that it has raised a second tranche of funding in its Series A funding. Amount of the funding was not disclosed, however, a recent regulatory filing indicates that the firm had raised $630,004 out of a $2.5M funding round in May. The funding came from JumpStart Ventures and individuals. As part of the funding, the company said it has added Catherine Stiefel to its board of directors. Stiefel was a Director at Stiefel Laboratories, which was acquired by GlaxoSmithKline for $3.6 billion in July. More information »